Arizona State University
Phoenix, Arizona, 85004, United States
NCT Number: NCT07839156
This is a 12-month, 2-arm randomized controlled trial (n=150) examining whether toddlers randomized at 12 months of age to 1.5 cup-equivalents/day of cow's milk-based dairy versus oat milk-based dairy, and followed to 24 months, have better growth, sleep, neurocognitive, and gut microbiome outcomes.
Trial opening soon.
Get Notified6 month–12 month
All sexes
Interventional
Not applicable
Phoenix, Arizona, 85004, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Toddlers in the cow's milk group will receive 1.5 cup equivalents per day of cow-based dairy (1 cup of fluid milk + ½ cup equivalent of cheese (0.75 oz.) or yogurt (1/2 cup)).
Toddlers in the oat milk group will receive 1.5 cup equivalents per day of oat milk (1 cup of fluid milk + ½ cup equivalent of cheese (0.75 oz.) or yogurt (1/2 cup)).
Time frame: At enrollment to the end of treatment at 12 months
Microbial DNA extracted from toddler stool samples will undergo shotgun metagenomic sequencing to identify the unique species present in the gut microbial community and evaluate the richness and abundance of microbes present in the stool.
Time frame: From enrollment to the end of treatment at 12 months
Toddler length will be assessed with a pediatric length board and reported in centimeters.
Time frame: From enrollment to the end of treatment at 12 months
Infant weight will be assessed with a calibrated scale and reported in grams.
Time frame: From enrollment to the end of treatment at 12 months
A questionnaire completed by the parent/caregiver that is normed for ages from birth through 90 years. The tool assesses adaptive behaviors (things people do to function in everyday life) in three domains: communication, daily living skills, and socialization.
Time frame: From enrollment to the end of treatment at 12 months
A widely used checklist completed by parents to assess children's early communication skills such as comprehension and use of gestures and words.
Time frame: From enrollment to the end of treatment at 12 months
Study staff will administer a structured 15-minute play session with the infant to objectively assess motor, visual, and early language skills.
Time frame: From enrollment to the end of treatment at 12 months
Sleep location, duration, quality, and interactions; validated for infants and toddlers through age 3 years; REDCap online. Scores range from 0-100 with higher scores representing healthier, more consolidated sleep patterns (e.g., shorter time to fall asleep, fewer and shorter night wakings).
Time frame: From enrollment to the end of treatment at 12 months
Actigraphy is a standard, valid, noninvasive measure for assessing sleep and circadian rhythm patterns across the life course. For infants and young children (e.g., toddlers), the actigraph is a small watch-like device that will be worn around the left ankle to record body motion (activity counts). The child will wear the devices for 7 continuous days and nights after all in-home visits. Constant assessment is necessary to capture the full development of sleep-wake patterns and circadian rhythmicity across toddlerhood. Home visits will be scheduled to avoid current illnesses or well-visits to avoid vaccination effects on sleep patterns. Primary sleep variables will be averaged across the recording period. Data will be reported in minutes of time that the child is awake or asleep.
Time frame: From enrollment to the end of treatment at 12 months
During actigraphy data collection, the parent/guardian will complete sleep diaries on the sleep of their toddler. Diaries will be used to identify artifacts that might affect motion (externally induced motion e.g. car seat, swing, or constricted motion e.g. swaddling), and to define sleep periods from actigraphy outputs for children prior to analysis with the sleep-wake algorithms. Primary sleep diary variables will be (1) bed/nap clock times attempted to sleep, (2) bed/nap clock times of sleep bout awakenings, and (3) time in bed or interval between attempted bed and wake times.
Time frame: From enrollment to the end of treatment at 12 months
Research personnel will objectively evaluate the caring environment in which a child is raised and parent-child interaction using this validated assessment. The inventory qualitatively assesses the quality and extent of stimulation, support, and learning resources available in a child's home environment.
Time frame: From enrollment to the end of treatment at 12 months
Habitual intake will be assessed via the Automated Self-Administered 24-hr recall software (ASA24) on 2 weekdays and one weekend day developed by the National Cancer Institute.
Time frame: From enrollment to the end of treatment at 12 months
Pre-post meal photos of the infant and their food will be provided by the parents. These images will be used to help corroborate dietary intake and behavior data.
Time frame: From enrollment to the end of treatment at 12 months
This questionnaire asks about breastfeeding, formula feeding, complementary feeding, introduction to solid foods, food allergies, and participation in the Special Supplemental Nutrition Assistance Program for Women, Infant, and Children.
Time frame: From enrollment to the end of treatment at 12 months
The USDA 6-Item Food Security Screener will be used to assess household food insecurity. Scores range from 0-6 with higher scores representing higher levels of food insecurity.
Time frame: From enrollment to the end of treatment at 12 months
Will be used to evaluate allergy exposures and risk across the study period. This is a checklist of various common allergies that parents report the child having or not having each allergy.
Time frame: From enrollment to the end of treatment at 12 months
Parents will be asked to classify the stool consistency using the picture-based Brussels Infant and Toddler Stool Scale (BITSS), developed specifically for non-toilet-trained children.
Time frame: From enrollment to the end of treatment at 12 months
To assess children's experiences of gastrointestinal and gastroesophageal reflux symptoms. A total score is calculated as a sum of responses from 36 questions. Higher scores indicate greater symptom burden, and scores range from 0 to 180
Trial opening soon.
Get NotifiedArizona State University
Other
Beyond the Bottle: Investigating the Differential Biological Effects of Cow's Milk and Oat Milk on Toddler Development
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05400005
Cardiometabolic Risk, Gut Microbiome
Singapore
View Trial DetailsNCT06876935
Gut Microbiome, Infant Growth
Phoenix, Arizona, United States
View Trial DetailsNCT07071181
Cardiovascular Diseases, Cognitive Function and Mood
Leeds, West Yorkshire, United Kingdom
View Trial DetailsNCT04078724
Dyssomnias, Gut Microbiome
Singapore
View Trial Details